News from

Cancer Research

Reset All Filters
467 Results
Support for trainees ensures a bright future for BRCA science

Support for trainees ensures a bright future for BRCA science

The Basser Center for BRCA Postdoctoral Fellowship Program, founded by Ilana Katz Sand and Michael Sand, provides support for one postdoctoral fellow for three years or the last two years of training for a clinical fellow.

New CAR T treatment opens doors for kidney patients
Anatomy of two kidneys

Image: jitendrajadhav via Getty Images

New CAR T treatment opens doors for kidney patients

An early Penn Medicine trial demonstrates CAR T cells can safely desensitize even the most challenging transplant candidates.

Matt Toal

2 min. read

GLP-1 use linked to lower breast cancer incidence in large cohort study
A person holding a GLP-1 applicator.

Image: Iuliia Burmistrova via Getty Images

GLP-1 use linked to lower breast cancer incidence in large cohort study

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.

2 min. read

Major gaps in online info for patients about AI and cancer

Major gaps in online info for patients about AI and cancer

In a new Penn Medicine study, researchers screened web pages to understand how patients are using AI in their searches in an effort to work with the emerging technology to offer more accessible, high-quality resources.

Fighting oral cancer with bioengineered chewing gum
A latex-gloved hand hoding a petri dish of medical chewing gum.

A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

(Image: Kevin Monko/Penn Dental Medicine)

Fighting oral cancer with bioengineered chewing gum

Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

2 min. read

A retrospective on CAR T cell therapy: From long shot to lifesaver
(From left) Bruce Levine, Stephan Grupp, Tom Whitehead, Emily Whitehead, Kari Whitehead, Carl June, David Porter.

(From left) Bruce Levine, Stephan Grupp, Tom Whitehead, Emily Whitehead, Kari Whitehead, Carl June, and David Porter.

(Image: Daniel Burke)

A retrospective on CAR T cell therapy: From long shot to lifesaver

More than 30,000 patients have undergone CAR T cell therapy since it was developed by immunologist Carl June and his team at the University of Pennsylvania.

1 min. read